Ladies and gentlemen. Welcome to the CAE First Quarter Conference Call. Please be advised that this call is being recorded. I would now like to turn the meeting over to Mr. Andrew Arnovitz. You may proceed Mr. Arnovitz.

Thank you. Good afternoon everyone, and thank you for joining us today. Before we begin, I’d like to remind you that today’s remarks, including management’s outlook and answers to questions contain forward-looking statements. These forward-looking statements represent our expectations as of today, August 10, 2022, and accordingly, are subject to change. Such statements are based on assumptions that may not materialize and are subject to risks and uncertainties. Actual results may differ materially, and listeners are cautioned not to place undue reliance on these forward-looking statements. A description of the risks, factors and assumptions that may affect future results is contained in CAE’s annual MD&A, available on our corporate website, and in our filings with the Canadian Securities Administrators on SEDAR and the U.S. Securities and Exchange Commission on EDGAR. On the call with me this afternoon, are Marc Parent, CAE’s President and Chief Executive Officer; and Sonya Branco, our Chief Financial Officer. After the remarks from Marc and Sonya, we’ll take questions from financial analysts and institutional investors. And following the conclusion of that Q&A period, we’ll open the call to questions from members of the media. Let me now turn the call over to Marc.

Thank you, Andrew, and good afternoon to everyone joining us on the call. We had a mixed performance in the first quarter with Civil delivering results in line with our view for strong annual growth and increased market share momentum. Defense results were disappointing. However, coming in very well short of our expectations. The shortfall was mainly due to unanticipated discrete charges on 2 of our legacy programs and increased intensity of the defense sector-wide headwinds that we’re facing in this early stage of our multiyear growth journey. Now we’d already factored into our prior outlook that the second half of the fiscal year would be stronger than the first, mainly because we’re still working our way through the lag effects of a protected period of less than onetime book to sales. And it takes time for new program awards to ramp up. We also expect that some of the additional headwinds in the first half, but they were significantly more acute than we thought they’d be. Now order activity is the best indicator of our future growth. And despite a challenging global environment for CAE overall, we secured over $1 billion in orders for a record $10 billion backlog and 1.12 book-to-sales ratio. In civil, we made excellent progress converting our large opportunities pipeline into $522 million of orders for a 1.09x book-to-sales ratio. Now this includes long-term training agreements with airlines and business aircraft operators and 11 full-flight simulator sales. Notable training contracts for the quarter involved several exclusive training agreements in the Americas, which adds to the long list of exclusive training agreements that Civil has signed in the last 1.5 years, with the vast majority of major airlines in the region. This quarter, -- they include a 3-year extension to a long-term exclusive training agreement with…

Thank you, Marc, and good afternoon, everyone. Consolidated revenue of $933.3 million was 24% higher compared to the first quarter last year. Adjusted segment operating income was $60.9 million compared to $98.4 million last year. And quarterly adjusted net income was $17.6 million or $0.06 per share compared to $0.19 in the first quarter of last year. This quarter’s results includes $28.9 million in unfavorable contract profit adjustments in defense, which accretes to a $0.07 negative EPS impact. We incurred restructuring integration and acquisition costs of $21.5 million during the quarter, including $16 million related to the Else-Harris military training and AirCentre acquisitions. Free cash flow was negative $182.4 million compared to negative $147.6 million in the first quarter last year. The decrease was mainly due to lower cash provided by operating activity. The decrease was partially offset by a lower investment in noncash working capital. We usually see a high level of investment in noncash working capital accounts during the first half of the fiscal year and tend to see a portion of these investments reversed in the second half. Growth and maintenance capital expenditures totaled $73.9 million this quarter, mainly for growth and specifically to add capacity to our global training network to deliver on the long-term exclusive training contracts in our backlog. Income tax recovery this quarter was $0.5 million for a negative effective tax rate of 16% compared to a positive effective tax rate of 18% for the first quarter last year. The income tax rate was impacted by restructuring integration and acquisition costs this quarter. And excluding these costs, the income tax rate this quarter was 21%, which is a rate we use to determine the adjusted net income of $17.6 million and adjusted EPS of $0.06. Our net debt position at the end of…

Thanks, Sonya. As we look to the period ahead, despite the prevailing macroeconomic headwinds and added defense sector related challenges, we continue to see a clear multiyear path to becoming a larger, more resilient and more profitable CEA. In civil, our outlook is as bright as ever. We’re in the early stages of an up cycle with near record margins with plenty of room to grow beyond that. We’ve invested both organically and inorganically to expand our training network globally, leveraging our position as the world’s largest civil aviation training company. A greater desire by airlines to a trust with their critical training and digital operational support and crew management needs, acute pilot demand and strong business jet travel demand are enduring positive underpinning a secular growth market. Now the unevenness of the global recovery is likely to continue for some time, but we’re ultimately in an excellent position to benefit from the multiyear cyclical market recovery that’s currently underway. We continue to expect strong growth in Civil this fiscal year, driven by high demand for pilot training as evidenced by robust full-flight simulator sales and exclusive long-term training agreements with security in recent quarters with virtually all major airlines in the Americas. We’re poised to continue growing market share from an expanded pipeline of civil training opportunities. And I believe these successes provide a compelling blueprint for what a broader global market recovery holds for CEA-- in Defense, despite the additional challenges that we encountered in the quarter, the positive long-term outlook that we shared at our Investor Day in June is unchanged. We’re on a multiyear journey to become a bigger and more profitable and the first and more critical link in that chain involves winning orders. Our record order intake last year for the first quarter confirm…

Thanks, Mark. Operator, we’ll now open the line to members of the investment community for their questions.

[Operator Instructions] Our first question comes from Kevin Chiang with CIBC.

Maybe I could dig into some of the details you gave in terms of what happened in defense. Marc, it sounds like you’re confident that it’s the provisions you’ve taken only relate to these 2 contracts. But I guess, historically, when we look at these types of issues, a lot of times, it ends up being a lot more systemic than just 1 or 2 contracts. Maybe you can give us a sense of why you’re confident that the issues that you found are isolated to these 2 contracts. Maybe what may these 2 contracts unique and why it’s not more systemic in your backlog? And maybe any changes in your bidding process that might have occurred as a result of maybe this revaluation?

Yes. Maybe I’ll take it in 2 parts, Kevin. Look, I’ll be the first one to tell you that the performance in the quarter certainly doesn’t meet our expectations or my expectations for the defense business as a whole. And look, I’ll start with maybe the specific charges that we took. Again, I’m not happy with them. And these were -- I would tell you, these are surprises to us that occurred in June as a discrete customer-led events that caused us to recognize these. But we re-baseline both programs following the cautionary discussions we had in June. And I think we’ve taken an appropriate approach going forward and having to recognize the charge that we took. And to give you a little bit more color on them, just to tell you that I feel pretty darn confident that can isolate these programs, because you would imagine just taking the step back a second, when you get impacts such as we’ve seen here, it forces a complete review of everything in your portfolio. You would have expected me to do that. So just to give -- go back on the programs. On the first one, on the Navy training contracts, Sinatra. This is where the customer demand has really outpaced our expectations. I mean we train, as I said in our remarks, we train at 5 naval air stations that want to be in corporate and the Navy has been trading at a very, very high rate, higher -- will be very frankly, higher than we did at and we did this years ago. It’s a legacy contract. Now we have put -- we have put cost reduction measures in place to improve the profitability on that program. But what’s happened now is a shrinking time to realize the benefit…

And maybe just like you just had an Investor Day was call in the middle of the quarter, the middle of the previous quarter. I guess, these issues weren’t evident at that time, I guess, just to state the obvious, when you agree from the outlook at that point in time, I guess, at what point did you realize that you have to start taking these provisions?

Late June, Late June. That’s when it happened. And yes, it did come as a surprise. I don’t like surprises. You don’t like surprises. We don’t like surprises. And -- but that’s what happened. And as I said, the -- as I highlighted by mark, the discrete charges, they’re noncash or onetime in nature. We’ve rebaselined every program in the portfolio. We’ve taken very specific actions on the rest of our programs. So I’m quite confident going forward. But if I expanded, look, even -- and I’m sure the follow-up question might be that -- and I think we’ve intimated in the remarks that even if you take those 2 charges out, the profitability of our defense business in the quarter is still very low. And I think we expected that. We expected that. Now we’d tell you I didn’t expect that much to be very frank with you, we you would be back half. So we -- but if it wasn’t for the charge that we’ve taken here, I think we largely could have probably maintained our outlook. But what we’ve had here, we just can I could expand upon that.

Our next question comes from Fadi Chamoun with BMO.

I guess I got a couple of questions. One is the guidance for mid-20% EBIT growth, if we’re assuming Civil is still on track to be mid-30% EBIT growth really implies a very strong performance in the defense in the next 9 months. Like you would have to be doing almost 45% growth in EBIT in defense in the next 9 months. to basically be in that mid-20% EBIT performance for the year. So I just want to make sure I’m understanding this because excluding the charges, the underlying profitability in Defense was only 2%, and you seem to suggest that the headwind that kind of pressure that margin will continue at least into the second quarter?

Well, it will gradually abate, but we’re still going to see it in the second quarter. And as I said, we see more of a substantial uplift in the second half, which has always been our outlook, but I don’t pronounce. I think, look, I’m not going to break it down from a sector standpoint, Fadi. We purposely did not do that. You would expect I think that when you have issues like we had in the quarter, we are adopting a company-wide effort on this. It’s not -- we are taking actions that not only affected the defense business, but the business as a whole to maintain the profitable growth profile that we’ve indicated in our outlook. The other thing I would tell you is that I talked about some of the -- although we’ve done really, I would say, really well in the quarter on orders and especially on defense orders, I think we’ve said in the past that not all orders are created equal. And there are some orders that we really, frankly, totally expected to happen in Q1 that did not happen. Now some of those orders, we have won them subsequently, I can tell you. And those turn into because the ones I’m talking about, which convert into revenue faster is products orders. And therefore, that -- when you take all of that into fact into consideration, you will get to the outlook that I talked about.

Okay. Maybe the follow-up is -- I mean you’ve always run a very kind of fixed cost contract business in the defense, I think the majority of your revenues are fixed contract business. We’ve never really had the types of contract issues in the past. Is there -- like what’s different that happened kind of recently to kind of make these cost performance deviate so much from your assumption. I guess you gave some explanation on the U.S. Navy contract. But is there anything changing in how the business is being awarded or the risk profile that you’re taking on these contracts that increases the risk of margin in defense? Or is this just a unique onetime kind of event here?

No. Look, I think you’re right. Look, first of all, you’re absolutely right that we haven’t seen this before. And again, all the time that I’ve been at CEA, we have never seen the many of impact in one quarter. No, you’re absolutely right. And we haven’t a habit of running out of contingency on a program like that. And as I mentioned before, the SENATRO-1, which is part of the chart, very specific in nature, we -- because of the contract being not being renewed at the time that we thought it would. We still think it would. So that’s one factor. And just maybe to give you an idea of your talked about the firm fixed price. About 80% of our contracts are about firm fixed price. Now that’s actually -- that’s a much better picture than we were when we were -- before the L3 Harris transaction now. And I wouldn’t be overly precured by that number because, remember, there’s a lot of service contracts in there, service contract, we are very, very high predictability. And all of the others, as I talked about, again, you get an event like this, it forces you. I’m not saying that we weren’t monitoring the program before. But clearly, there’s an extra level of scrutiny that occurs when a program like this happens. And when we look at the contract, the fixed price contract that we have for the classified program that I visited just a couple of weeks ago, this is a very complex program. And to be -- this -- we inherited this contract through the acquisition of Ultra Harris. Would I wish that this contract, which is a development program had been bid differently as not a firm fixed price contract Yes, I would. Do I think…

Our next question comes from Cameron Doerksen with National Bank Financial.

I guess a question on the health care business. I mean, I appreciate it’s still pretty small, but there’s been, I guess -- maybe this is not the right term, but a bit of a revolving door on leadership of that business. So I’m just wondering if you can maybe talk about the change there. Why should investors think that this business is now going to be on track to ultimately getting to more consistent profitability?

Well, like I said, Cameron, I absolutely understand this is a show me story. What I would tell you is the show me with 6 consecutive quarters of double-digit revenue growth. Now that has to translate into bottom line growth. I’ve said it before and it’s true, it continues to be true that we’ve invested substantially in R&D and SG&A, meaning sales force to be able to get the results that we have. I would tell you the change that we had at leadership of health care has gone very, very well. I’ve not got a comment, although I will agree with you that we have had somewhat of a revolving door at a health care cannot debate that with you. I can tell you that I’m very, very happy with the performance of Jeff Evans, who’s leading the business at the moment. He’s acting as interim at the moment. But I can tell you, I’m very satisfied with the performance so far. And I would tell you that Jeff himself, who is a 19-year veteran of GE Healthcare, and I’ve been running large P&Ls for GE. He is the architect of -- or the main architect as Head of Sales for the run-up in revenue that you’ve seen. I can tell you as well that we’ve taken significant steps to improve the profit profile by reducing costs in the business. And as you’ve heard me say before, and continues to be true, the profitability of the products that we have in health care are very good, are very good. We are suffering -- and perhaps this is not surprising. We are suffering from inefficiencies because we have a high degree of parts shortage. So what you have is if you were to go to our facility down in Sarasota, which I’ve been quite a few times, you would see basically 3/4 built products, medical medicine, for example. And then when we get the parts, we complete them, we take them out of stores, we put the parts and we retest them and we ship that. You can imagine that, that causes a lot of inefficiencies over time, basin quality issues, all kinds of issues that are not great for your profitably profile. But I’m quite confident that a lot of those are abating themselves. And so I’m quite happy with the way forward. And I think you’ll see some progress in the quarters to come.

Yes, I agree, Marc. It’s a great summary. I’ll just add a little bit of additional color on some drivers of the variability. So -- there is some R&D funding investment tax credits that go through health care as well as the rest of the business. And these things can be lumpy. So last year, it was actually a tailwind this quarter was actually a headwind. So in the larger organization that doesn’t have a lot of impact, but on health care that’s much smaller P&L, these kind of variabilities have a larger impact on the quarter-over-quarter. So in addition to everything that Marc just walked through, there is -- we have to consider a little bit of, I guess, nonroutine variability coming from R&D and investment tax credits.

Our next question comes from Konark Gupta with Scotiabank.

So I just wanted to follow up on the defense mix here. So just trying to understand, Marc, how do these 2 adjusted contracts impact the margin mix for Defense segment over the next 3 quarters as well as your long-term outlook for double-digit margin?

Well, I think the first thing I’ll tell you is, as I said in the remarks that although we bid in that way, we’re quite confident the rebased lining of the programs that we’ve won, all the progress that we’ve won in recent time, certainly, since we’ve had the new organization in place under Dan Gelston, the profitability profile of that backlog supports our objective of low double-digit margin defense. That’s the first thing I would tell you. I would tell you as well that we have a very firm handle on the inefficiencies and other impacts that we had that affect the profitability of our business. And I’m talking -- I’ve taken the 2 programs charges to decide for 1 second. I’m just saying the inherently low percentage of profitability and defense in this quarter, this results from, again, the inefficiencies that we had on labor, on parts, sometimes lead times on parts have doubled, and the cost themselves have changed and introduced all kinds of inefficiencies that you would get on over time, things like that. Now again, I would say that -- and again, a bit repeating myself that we had always anticipated that the first couple of quarters of this year in defense would be challenging for some of these factors that we could see. What I would say is that we’re worse than we anticipated. It took us longer to get back hired clear personnel, than we thought. Part shortages impacted us more than we thought. But we have a pretty good handle of it and quite confident in that these factors as they affect us will abate in the second half. So again, leading into defense contribution to the outlook that we’ve given. The other factor I would say as well is if you look at the amount of bid and proposal money. Now our bid proposal costs this quarter are very materially as we track some very large opportunities in our bid pipeline. And we talked about some of this in our Investor Day. Now it’s not very different from our internal expectations that we would bid higher. But some of these programs, I can tell you a couple of big Canadian programs came at the same time in the quarter, and we cannot afford not to bid them. They are so large. So that causes a disproportionate amount of business proposal costs in this quarter, which is not necessarily going to be the same as we go throughout the year. And just again, to help you understand the quantum here. The expenses on big and proposals roughly, again, doubled over last year and are up pretty much the same thing this year. But what you’re seeing here is the prework that we’re doing to capture the opportunities that Dan Gelson outlined at our first Investor Day, we’re attacking those hard. And I think all of that answers your question as where we’re going in defense and in terms of its profitability.

Our next question comes from Benoit Poirier with Desjardins Capital Markets.

Just to come back to Healthcare. Given the favorable valuation for health care companies these days in light of the performance, would you consider potentially divesting these assets and just searching for a new leader, what are the qualification that you’re looking for in terms of a new leader for health care?

Well, I’ll take your second one is basically a leader is going to drive the profitable growth of our health care business going to basically make it a more sizable contribution and accretive contribution to CEA’s results. That’s the minimum threshold for that. And as I said before, I think so far, Jeff Evans is demonstrating to me that, that is the case. So there’s more to see on that front. And look, as I’ve said before, I am very confident in how health care fits into CEA’s overall portfolio, and it very much supports our noble mission, and there is substantial synergies across our organization in terms of facilities, in terms of people and their technology. So it’s part of our portfolio and have no there’s no thought about changing that.

And just looking at the Civil EBIT margin that came in below our expectation on the back of a higher utilization rate and lower equipment deliveries where margins tend to be lower. So could you provide more color on what’s putting pressure on margin, whether it’s more equipment, commercial business jet and how we should expect Civil margins to bounce back throughout the year?

Well, look I will tell you civil margins certainly met my expectations. So I think I said this many times before, Benoit, in every part of our business I would look at this quarter-to-quarter, but having said that I’m very, very bullish and very satisfied with both the civil business. In the quarter and of course the indicators the reads the outlook. you look at the orders, you look at the training utilization that is 71% that is prior to COVID, that is a pretty good utilization. And we’re seeing if you look at the results and I’m sure you are, you look at the results with a fine tooth comb, you’re seeing the cost reduction translate into a result. And we’re all ready, even at 80%. Don’t look at it quarter for quarter because utilization we said it before is not a perfect measure. You always have product mix that is less favorable in the quarter. This quarter we have higher R&D expenses to support some of our innovations like for examples eVTOL that we spoke at Investor Day. So in this quarter pretty down the mix and I fully expect we might look the next score the other way around. So I remain very firm that this business is going to realize strong results in the future. And our results -- to me what I say supports that very bullish. [Technical Difficulty]

Our next question comes from the line of Tim James of TD Securities.

I just want to change the discussion a little bit here although sticking with kind of the defense side of the business. I’m wondering if you can update us on any evidence you were seeing, whether it’s in this most recent quarter or maybe the last couple of quarters, a growing demand for virtual military training relative to Live are just new applications for simulation and the technology that support that secular growth story for simulation-based training, I’m thinking of aviation more specifically. [Technical Difficulty]

Pardon me, this is Frank. Can I introduce the next question from Tim James from TD Securities.

I’m wondering if you can update us on any evidence you’re seeing whether it’s in this most recent quarter or the last couple of quarters a growing demand for virtual military training relative to live, are just new applications for simulation and the technology that support that secular growth story for simulation-based training, I’m thinking of aviation more specifically.

When you say aviation sports specifically, can you just expand on that, what you mean there?

Well, I mean, military aviation training as opposed to some of the other sort of fields, the other domains that you’ve gotten involved in recent years. I’m just thinking specifically of aviation applications.

Well, I would tell you, look, the trend that we’ve seen increased use of simulation for training in military and continues to increase for very real reasons that -- what does the military do and when they’re not in operations, they train for operations. That’s all that they do and in order to maintain readiness. And they need to do that, and they need to do that in an environment where costs are always an issue, cost ae an issue. So there is still plenty of room to grow the use of simulation-based training not only, I would say, using full-flight simulators, but using new technologies, and I think maybe that’s what you’re intimating do, which we are investing in significantly and are deploying, in some cases, to like, for example, AR/VR, as just an example. One are the contracts that we announced this quarter it goes to that point where we’re deploying we’re actually developing using AR/VR, a deployable trainer for people to be able to train when they’re in operations or even down to a local shares office, for example, what they would have done gunnery range. So rather than having a full gun rate range with real guns, for example, then you can do it virtually, and you can do it deploy. That’s just one example. There’s plenty of that to go. And some of the when I look at some of the very big real opportunities that are in our pipeline represent that. Again, I would point to you at the macro level, look at the bid pipeline, the amount of bids that we have there that we have out there has increased quite substantially and the orders that are at 5-year highs in terms of our -- if I look at our book-to-bill, it’s the highest been out of 12 months trailing basis, which is, I say, I always look at that and look at the 12-month trailing basis on our order intake. It’s the highest it’s been in 5 years. I think that’s demonstrating where we’re going here is growth in defense.

My other question, just turning to the Air Center acquisition. At the time of the transaction, it was indicated that sort of pre-pandemic, that was a USD 150 million, I believe it was annual revenue business and with $55 million in EBITDA U.S. as well. How should we think about kind of the -- or we would be wildly off if we kind of thought about that business as contributing a similar amount sort of today at this point if we think about the first quarter? Is there anything specifically different relative to kind of pre-pandemic? Is it simply lagging kind of as the rest of the Commercial Aviation business is relative to sort to pre-pandemic? I’m just trying to get a bit of a sense for what the contribution is in the quarter.

No, look, I’ll ask Soni, if she wants to tell you what the contribution is. But I would -- first, I would tell you, it’s still very early in the integration. We’re still basically in the very early innings on that, but we’re on track. I feel very, very comfortable with the reaction of customer-specific airlines. I had meetings with airlines specifically, most recently at Farma, they’re very happy with CEA having doing this business. And you yourself can tell it, we read it every single day, right, about the amount of inefficiencies that are out there, gates, baggage hiders, pilots, aircrew, being in the right locations with airplanes. That’s all things that our software solutions are help offer to help manage and optimize for greater efficiency. And having to that, that’s going to be, and we’re seeing an increased demand for CAE in this field. So I’m very optimistic in this regard -- again, the integration is on track. And everything that we said in terms of how this business would contribute to CAE, to me, is right on track.

I’ll just add, for the quarter itself, it was not necessarily overly significant, but we’re working through the integration on track, and we expect it to ramp up nicely through the fiscal year. Now those benchmarks on pre-COVID are an indication of what this business can do at a more recovery rate than before even us adding to the investment and elevating this with our bundled sales. So ultimately, as the recovery plays out, we’re very confident we can get to those numbers and even beat them as the recovery grows over the next couple of years.

Our next question comes from Noah Poponak with Goldman Sachs.

The 2 programs that took a charge in defense. When were those contracts written, when did those programs start?

They’re legacy contracts, they were -- we took over one -- the one that we call the classified program was signed 2018 odd that Sinatra. Prior to us by -- we took over that contract when we acquired L3, the Sinatra contract with the legacy contracts in 2018. I know that for sure.

Okay. And what actually cost more? Where was the cost over in?

Well, in the case of Sinatra specifically, as I said, this is a contract specifically where the customer is training more than we bid it on. It’s a simple event, okay? And we had cost mitigations and other actions to make less impact of that, I would tell you, missed bid at the time. Now I can tell you, we don’t bid that way now. We have complete -- in the past couple of years, we’ve refined the -- how we look at risk and how we bid military programs. But this is one specifically that because of this situation where we were with the customer is still utilizing those training assets at 5 basis at a much higher level of demand that was anticipated at the time, we’re really -- that’s what we’re facing here. Now again, we put mitigating factors in the reduction to improve efficiency to improve that program, and we fully expected that the contract, we get an RFP to be able to extend that contract or to renew that contract because it ends in and about less than 9 months. Now that, as I said, somewhat very surprisingly and counterintuitive because of the fact that they’re using is so high. Basically, we didn’t get -- not only did we not get the contract renewal, but the IDIQ or getting a bit technical on this, the IDIQ number was changed. In which case, basically what it says is we had no additional period of performance in which for our cost reductions or other measures that we put in place to improve the profitability of that program to take hold. We just ran out of time. So basically, you have to recognize the loss at that point. And that’s what happened. Now do I think that, that contract will go forward. The Navy needs this train. It’s going to happen. So to me, we haven’t baked in any upside on that. But again, stay tuned on that one.

So if those 2 are categorized as misbid what you’re -- the way you run the business today, you don’t bid that way. What percentage of the revenue base at this point is exposed to possibly having been misbid?

Well, I would tell you that, as I said before, when you get something like this, you take very specific actions, and again, I’m not going to say we weren’t looking at our programs before, of course, we were. But we’ve taken some very specific actions, including, I would tell you, the establishment of a centralized program management organization, a center of excellence, if you will. And we -- this was always part of our L3 Harris merger integration plan, but we’ve accelerated to bolster basically company program -- company-wide program excellence. So we have re-baseline and triggered a complete top-down review of our portfolio on all of our programs to make sure that we have the right staffing, the right contractual provisions and maximum visibility and transparency to make sure we don’t get surprised again. I’m never going to say never, okay? But what I would tell you, though, is that -- all the programs, including the ones that were bid prior have been looked at to make sure that we have the right provisions and the right cost investments and the right assumptions that we don’t get surprised. That’s what we put.

And Marc, that review is complete or that review is in process?

No, that review is complete.

And did I hear you correctly earlier committing to a 10% operating margin in this business in your fiscal ‘24 -- or did I hear that incorrectly?

No. No, you didn’t hear me say that. You -- you’ve heard me say, I believe, that if not, I was an corrected, that our target for this business is low double-digit returns in the US. And that the -- if I look at the programs that we’ve signed up that in our backlog, they support a double -- that they support that that backlog supports that goal. Now we obviously have to execute on them. And that’s where the measures that we’ve taken, the centralized program management organization, for example, gives me that confidence. Again, I think as I said before, I’ve seen this kind of thing before running major programs. When you get this kind of impact, you just 2 things are slightly different. And I would tell you you’ve got this, and I feel very confident about the team in place Defense to make it happen.

Operator, thank you. We’re now going to use the last minute or so that we have here, unfortunately, not a lot of time to open the call to members of the media, if there are any questions.

[Operator Instructions] We have a question from Allison Lampert with Reuters.

Marc, you talked a bit about some of the supply chain challenges you’ve had. Could you be a little bit more specific? Have you seen issues with shortages of semiconductor?

Yes, we have. In fact, that’s been especially acute actually surprisingly in our health care business. And I say surprising and that’s where we have the highest concentration, I think, on a -- in an individual Madigan of chips, which had a specific shortage. But we’ve seen it. Now I would tell you that I think, overall, we managed it pretty well. So it’s not just chips, but it’s really what we’re seeing across the board. It’s that lead times for parts have extended it, in some cases, a little bit more than double which it makes -- it’s not only issue the impact of the parts themselves not being there at the time that we need them is that, obviously, that REITs have it to schedules. So in order for us to maintain schedules, we have to do all kinds of things like, for example, paying expedite charges for parts. We have to conduct over time. We have conducted out-of-sequence work which introduce all kinds of inefficiency. So maybe I’ll just stand there, Alison.

And just to follow up, are you seeing -- what kind of demand are you seeing for MAX 10 simulator?

Oh, the MAX. I’m sorry. I’m sorry, the MAX. Okay. No, look, I think demand for the simulator for the MAX aircraft overall and not basically break it down to MAX8 or MAX10 they’re very strong, very strong, and it’s part of the backlog that we’ve signed and simulated orders over the past -- as well as training that we’ve signed in the last 12 months.

And just to follow up on semiconductors. Would you say that the shortages you’re seeing now are more acute on the chip side, whether it’s in aviation specifically than in the past because we’ve seen historically more on the auto side than in aviation.

Look, I can’t comment about the other industries in detail except for what I read in your newspaper. But what I’d tell you is, look, the impacts have been real for us. But we’re -- as I said, we know where they are. We have -- we know what our bill of materials is and we know when we need the parts to support our schedule. So we have harmonized schedules for those parts to support the forecast that we have that we presented that we take to support the forecast that we have today.

Great. So operator, that’s all the time we have for today. I want to thank all of our participants for joining us on the call and remind you that a transcript will be available on CAE’s website. Thank you.

That does conclude the conference call for today. We thank you for your participation and ask that you please disconnect your line. Have a great day, everyone.